Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
The impact of micronutrient supplementation on the health of Zambian adults with particular emphasis on intestinal infection
ISRCTN ISRCTN31173864
ClinicalTrials.gov identifier
Public title The impact of micronutrient supplementation on the health of Zambian adults with particular emphasis on intestinal infection
Scientific title Integrity of small intestinal antimicrobial defence in relation to micronutrients in Zambian adults
Acronym N/A
Serial number at source 067948
Study hypothesis To determine if a multiple micronutrient supplement boosts intestinal innate immunity in adults living in an urban environment in Africa.
Lay summary
Ethics approval Obtained from two ethics committees:
1. University of Zambia Research Ethics Committee
2. London School of Hygiene and Tropical Medicine Research Ethics Committee
Study design Randomised controlled trial
Countries of recruitment Zambia
Disease/condition/study domain Intestinal innate immunity
Participants - inclusion criteria All adults (over 18 years of age, either sex) resident within a defined geographical area of Misisi compound, Lusaka, Zambia, have been invited to participate.
Participants - exclusion criteria Does not meet inclusion criteria
Anticipated start date 01/06/2003
Anticipated end date 01/01/2007
Status of trial Completed
Patient information material
Target number of participants 500
Interventions Randomised, placebo-controlled trial of solid tablet formulation of 15 micronutrients, administered daily, with cross-over after two years.

The anticipated end date of this trial has been shortened to 1st January 2007, the previous anticipated end date was 31/08/2007.
Primary outcome measure(s) 1. Frequency of diarrhoeal disease
2. CD4 count in human immunodeficiency virus (HIV) seropositive participants
3. Expression of antimicrobial peptides in small intestinal tissue and secretions
4. Change in micronutrient status
Secondary outcome measure(s) No secondary outcome measures
Sources of funding The Wellcome Trust (UK) (grant ref: 067948)
Trial website
Publications 1. 2008 results in http://www.ncbi.nlm.nih.gov/pubmed/18842788
2. 2010 results in http://www.ncbi.nlm.nih.gov/pubmed/20604937
Contact name Dr  Paul  Kelly
  Address Tropical Gastroenterology & Nutrition Group
University of Zambia School of Medicine
Nationalist Road
  City/town Lusaka
  Zip/Postcode -
  Country Zambia
  Tel +260 1 252269
  Fax +260 1 252269
  Email m.p.kelly@qmul.ac.uk
Sponsor London School of Hygiene and Tropical Medicine (UK)
  Address Research Grants and Contracts Office
Keppel Street
  City/town London
  Zip/Postcode WC1E 7HT
  Country United Kingdom
  Tel +44 (0)20 7827 2678
  Fax +44 (0)20 7927 5636
  Email Penny.Ireland@lshtm.ac.uk
  Sponsor website: http://www.lshtm.ac.uk
Date applied 22/07/2005
Last edited 02/12/2010
Date ISRCTN assigned 22/07/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central